1. Home
  2. BLRX vs ARBK Comparison

BLRX vs ARBK Comparison

Compare BLRX & ARBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • ARBK
  • Stock Information
  • Founded
  • BLRX 2003
  • ARBK 2017
  • Country
  • BLRX Israel
  • ARBK United Kingdom
  • Employees
  • BLRX N/A
  • ARBK N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • ARBK Finance: Consumer Services
  • Sector
  • BLRX Health Care
  • ARBK Finance
  • Exchange
  • BLRX Nasdaq
  • ARBK Nasdaq
  • Market Cap
  • BLRX 17.1M
  • ARBK 18.6M
  • IPO Year
  • BLRX 2011
  • ARBK 2021
  • Fundamental
  • Price
  • BLRX N/A
  • ARBK $0.67
  • Analyst Decision
  • BLRX Strong Buy
  • ARBK Hold
  • Analyst Count
  • BLRX 2
  • ARBK 1
  • Target Price
  • BLRX $19.00
  • ARBK N/A
  • AVG Volume (30 Days)
  • BLRX 52.2K
  • ARBK 19.5M
  • Earning Date
  • BLRX 11-24-2025
  • ARBK 11-19-2025
  • Dividend Yield
  • BLRX N/A
  • ARBK N/A
  • EPS Growth
  • BLRX N/A
  • ARBK N/A
  • EPS
  • BLRX N/A
  • ARBK N/A
  • Revenue
  • BLRX $17,251,000.00
  • ARBK $24,043,000.00
  • Revenue This Year
  • BLRX N/A
  • ARBK $183.90
  • Revenue Next Year
  • BLRX N/A
  • ARBK $26.78
  • P/E Ratio
  • BLRX N/A
  • ARBK N/A
  • Revenue Growth
  • BLRX 1.19
  • ARBK N/A
  • 52 Week Low
  • BLRX $2.30
  • ARBK $0.15
  • 52 Week High
  • BLRX $22.60
  • ARBK $1.55
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 69.50
  • ARBK 74.62
  • Support Level
  • BLRX $3.57
  • ARBK $0.25
  • Resistance Level
  • BLRX $4.56
  • ARBK $0.94
  • Average True Range (ATR)
  • BLRX 0.27
  • ARBK 0.07
  • MACD
  • BLRX 0.08
  • ARBK 0.05
  • Stochastic Oscillator
  • BLRX 87.13
  • ARBK 66.74

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About ARBK Argo Blockchain plc

Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.

Share on Social Networks: